136 related articles for article (PubMed ID: 24816305)
1. Treatment outcomes of rapid desensitisation protocols.
van Nunen S
Intern Med J; 2014 May; 44(5):431-3. PubMed ID: 24816305
[No Abstract] [Full Text] [Related]
2. Treatment outcomes of rapid desensitisation protocols for chemotherapeutic agents and monoclonal antibodies following hypersensitivity reactions.
Kuo JC; Hawkins C; Yip D
Intern Med J; 2014 May; 44(5):442-9. PubMed ID: 24393214
[TBL] [Abstract][Full Text] [Related]
3. Desensitization protocol for rituximab-induced serum sickness.
Fajt ML; Petrov AA
Curr Drug Saf; 2014; 9(3):240-2. PubMed ID: 24861993
[TBL] [Abstract][Full Text] [Related]
4. Desensitization to rituximab in a multidisciplinary setting.
Amorós-Reboredo P; Sánchez-López J; Bastida-Fernández C; do Pazo-Oubiña F; Borràs-Maixenchs N; Giné E; Valero A; Creus-Baró N
Int J Clin Pharm; 2015 Oct; 37(5):744-8. PubMed ID: 25999014
[TBL] [Abstract][Full Text] [Related]
5. Successful rapid rituximab desensitization for hypersensitivity reactions to monoclonal antibodies in a patient with rheumatoid arthritis: a remarkable option.
Abadoglu O; Epozturk K; Atayik E; Kaptanoglu E
J Investig Allergol Clin Immunol; 2011; 21(4):319-21. PubMed ID: 21721382
[No Abstract] [Full Text] [Related]
6. Drug desensitization in the management of hypersensitivity reactions to monoclonal antibodies and chemotherapy.
Mezzano V; Giavina-Bianchi P; Picard M; Caiado J; Castells M
BioDrugs; 2014 Apr; 28(2):133-44. PubMed ID: 23990250
[TBL] [Abstract][Full Text] [Related]
7. Rituximab and lung disease.
O'Connor MB; Phelan MJ
Ir Med J; 2012 Oct; 105(9):314. PubMed ID: 23240291
[No Abstract] [Full Text] [Related]
8. A modified protocol for rapid desensitization to chemotherapy agents.
Vidal C; Méndez-Brea P; López-Freire S; Bernárdez B; Lamas MJ; Armisén M; Rodríguez V; Luna I; Castro-Murga M
J Allergy Clin Immunol Pract; 2016; 4(5):1003-5. PubMed ID: 27349174
[No Abstract] [Full Text] [Related]
9. Incidence of infusion-related reaction to monoclonal antibody rituximab: a national kidney and transplant institute experience.
Montoya JE; Luna HG; Vergara NG; Amparo JR; Cristal-Luna GR
Ann Acad Med Singap; 2012 Mar; 41(3):125-6. PubMed ID: 22538739
[No Abstract] [Full Text] [Related]
10. Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment.
Brennan PJ; Rodriguez Bouza T; Hsu FI; Sloane DE; Castells MC
J Allergy Clin Immunol; 2009 Dec; 124(6):1259-66. PubMed ID: 19910036
[TBL] [Abstract][Full Text] [Related]
11. Desensitization for drug hypersensitivity.
Adkinson NF
J Allergy Clin Immunol; 2008 Sep; 122(3):581-2. PubMed ID: 18774393
[No Abstract] [Full Text] [Related]
12. Rapid Drug Desensitization With Rituximab in 24 Cases: A Single-Center Experience.
Görgülü B; Seval GC; Kendirlinan R; Toprak SK; Özcan M; Bavbek S
J Investig Allergol Clin Immunol; 2019; 29(6):468-470. PubMed ID: 31530515
[No Abstract] [Full Text] [Related]
13. Rapid drug desensitization for hypersensitivity reactions to chemotherapy and monoclonal antibodies in the 21st century.
Castells Guitart MC
J Investig Allergol Clin Immunol; 2014; 24(2):72-9; quiz 2 p following 79. PubMed ID: 24834769
[TBL] [Abstract][Full Text] [Related]
14. [Castleman's disease: Rapid desensitization for hypersensitivity reaction to rituximab].
Boin C; Lambert S; Thomann P; Aujoulat O; Kieffer P
Rev Med Interne; 2016 Jun; 37(6):433-6. PubMed ID: 26415921
[TBL] [Abstract][Full Text] [Related]
15. Are antineoplastic drug acute hypersensitive reactions a submerged or an emergent problem? Experience of the Medical Day Hospital of the Fondazione IRCCS Istituto Nazionale Tumori.
Ferrari LA; Fanetti G; Rossi FG; Brambilla MC; Re B; Buzzoni R
Tumori; 2014; 100(1):9-14. PubMed ID: 24675484
[TBL] [Abstract][Full Text] [Related]
16. A case of coronary hypersensitivity (Kounis) syndrome associated with mid-ventricular ballooning pattern, intracoronary thrombosis and troponin elevation.
Gori T; Münzel T
Int J Cardiol; 2011 Jun; 149(3):377-8. PubMed ID: 21420182
[No Abstract] [Full Text] [Related]
17. [Use of pertuzumab and docetaxel desensitization in oncological patient; apropos of a case].
Guerrero Bautista R; Chica Marchal A; García Simón MS; Ferris Villanueva E; Pérez Cañadas P; De Andrés Bautista M
Farm Hosp; 2014 Nov; 38(6):491-3. PubMed ID: 25542663
[No Abstract] [Full Text] [Related]
18. A case series of pediatric oncology patients undergoing successful rapid etoposide desensitization.
Wright TE; Shah MD; Rider NL; Porea TJ; Musick MA; Miller J; Daves M; Foster JH; Anvari S
Pediatr Allergy Immunol; 2019 Aug; 30(5):579-582. PubMed ID: 30963632
[No Abstract] [Full Text] [Related]
19. Desensitisation overcomes rituximab- and tocilizumab-related immediate hypersensitivity in childhood.
Demir S; Soyer O; Bilginer Y; Sag E; Sahiner UM; Buyuktiryaki B; Sekerel BE; Ozen S
Clin Exp Rheumatol; 2020; 38(3):552-557. PubMed ID: 31820716
[TBL] [Abstract][Full Text] [Related]
20. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases.
Castells MC; Tennant NM; Sloane DE; Hsu FI; Barrett NA; Hong DI; Laidlaw TM; Legere HJ; Nallamshetty SN; Palis RI; Rao JJ; Berlin ST; Campos SM; Matulonis UA
J Allergy Clin Immunol; 2008 Sep; 122(3):574-80. PubMed ID: 18502492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
